SEC 13F Intelligence

Birchview Capital, LP / NBIX

Birchview Capital, LP’s Neurocrine Biosciences Inc Position

Does Birchview Capital, LP own Neurocrine Biosciences Inc (NBIX)? Yes — 27.2K shares worth $4M (+2.04% of its 13F portfolio) as of Q1 2026.

Position Value
$4M
Q1 2026
Shares
27.2K
% of Portfolio
+2.04%
Quarters Held
30
currently held

Position History NBIX

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $5MQ2 ’19: $5MQ3 ’19: $5MQ4 ’19: $6MQ4 ’19Q1 ’20: $6MQ2 ’20: $10MQ3 ’20: $8MQ4 ’20: $8MQ4 ’20Q1 ’21: $8MQ2 ’21: $8MQ3 ’21: $8MQ4 ’21: $8MQ4 ’21Q1 ’22: $8MQ2 ’22: $8MQ3 ’22: $9MQ4 ’22: $10,062Q4 ’22Q1 ’23: $8,527Q2 ’23: $8MQ3 ’23: $9MQ4 ’23: $10MQ4 ’23Q1 ’24: $11MQ2 ’24: $6MQ3 ’24: $3MQ4 ’24: $4MQ4 ’24Q1 ’25: $3MQ2 ’25: $4MQ3 ’25: $4MQ4 ’25: $4MQ4 ’25Q1 ’26: $4Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202627.2K$4M+2.04%
Q4 202527.2K$4M+2.26%
Q3 202528.7K$4M+3.04%
Q2 202530.9K$4M+3.86%
Q1 202530.2K$3M+2.90%
Q4 202430.2K$4M+3.36%
Q3 202430.2K$3M+3.02%
Q2 202442.2K$6M+5.39%
Q1 202477.2K$11M+8.70%
Q4 202377.2K$10M+7.98%
Q3 202377.2K$9M+7.40%
Q2 202384.2K$8M+5.95%
Q1 202384.2K$8,527+6.68%
Q4 202284.2K$10,062+7.11%
Q3 202285.2K$9M+6.37%
Q2 202285.2K$8M+6.04%
Q1 202289.2K$8M+6.02%
Q4 202189.2K$8M+4.90%
Q3 202180.2K$8M+5.23%
Q2 202180.2K$8M+4.67%
Q1 202180.2K$8M+4.63%
Q4 202080.2K$8M+4.43%
Q3 202078.0K$8M+5.01%
Q2 202078.0K$10M+5.75%
Q1 202074.0K$6M+5.68%
Q4 201955.0K$6M+4.30%
Q3 201955.0K$5M+3.30%
Q2 201955.0K$5M+2.82%
Q1 201955.0K$5M+3.04%
Q4 201855.0K$4M+3.72%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of NBIX.